3xFLAG-dCas9/pCMV-7.18848 bp40080012001600200024002800320036004000440048005200560060006400680072007600800084008800M13 fwdCMV enhancerCMV promoterstart codon3xFLAGdCas9SV40 NLShGH poly(A) signalSV40 promoterT7 promoterM13 revlac operatorlac promoterCAP binding siteoriAmpRAmpR promoterf1 ori

基本信息

载体名称
3xFLAG-dCas9/pCMV-7.1
载体抗性
Ampicillin
载体长度
8848 bp
载体类型
CRISPR Plasmids
复制子
ori
载体来源
Fujita T, Fujii H.
拷贝数
High copy number
启动子
SV40

质粒操作方法

质粒复溶方法

  1. 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
  2. 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
  3. 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
  4. 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
  5. 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
  6. 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
  7. 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。

通用质粒转化方法

  1. 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
  2. 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
  3. 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
  4. 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
  5. 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。

3xFLAG-dCas9/pCMV-7.1 质粒 (编号: V012353) 注释

LOCUS       3xFLAG-dCas9_pCM        8848 bp DNA     circular SYN 01-JAN-1980
DEFINITION  Plasmid for expression in mammalian cells of FLAG(R)-tagged 
            catalytically inactive dCas9, for engineered ChIP (enChIP) 
            purification of specific genomic regions.
ACCESSION   .
VERSION     .
KEYWORDS    3xFLAG-dCas9 pCMV-7.1
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 8848)
  AUTHORS   Fujita T, Fujii H.
  TITLE     Efficient isolation of specific genomic regions and identification 
            of associated proteins by engineered DNA-binding molecule-mediated 
            chromatin immunoprecipitation (enChIP) using CRISPR.
  JOURNAL   Biochem. Biophys. Res. Commun. 2013;439:132-6.
  PUBMED    23942116
REFERENCE   2  (bases 1 to 8848)
  AUTHORS   Fujii Lab / Addgene #47948
  TITLE     Direct Submission
REFERENCE   3  (bases 1 to 8848)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Biochem. 
            Biophys. Res. Commun."; date: "2013"; volume: "439"; pages: "132-6"
COMMENT     SGRef: number: 2; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..8848
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     primer_bind     141..157
                     /label=M13 fwd
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     enhancer        318..697
                     /label=CMV enhancer
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        698..901
                     /label=CMV promoter
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     CDS             928..930
                     /codon_start=1
                     /product="start codon"
                     /label=start codon
                     /note="ATG"
                     /translation="M"
     CDS             931..996
                     /label=3xFLAG
                     /note="three tandem FLAG(R) epitope tags, followed by an 
                     enterokinase cleavage site"
     CDS             1000..5103
                     /label=dCas9
                     /note="catalytically dead mutant of the Cas9 endonuclease
                     from the Streptococcus pyogenes Type II CRISPR/Cas system"
     CDS             5116..5136
                     /codon_start=1
                     /product="nuclear localization signal of SV40 large T
                     antigen"
                     /note="SV40 NLS"
                     /translation="PKKKRKV"
     polyA_signal    5189..5811
                     /label=hGH poly(A) signal
                     /note="human growth hormone polyadenylation signal"
     promoter        5840..6169
                     /label=SV40 promoter
                     /note="SV40 enhancer and early promoter"
     promoter        complement(6208..6226)
                     /label=T7 promoter
                     /note="promoter for bacteriophage T7 RNA polymerase"
     primer_bind     complement(6240..6256)
                     /label=M13 rev
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     protein_bind    complement(6264..6280)
                     /label=lac operator
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be 
                     relieved by adding lactose or 
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     promoter        complement(6288..6318)
                     /label=lac promoter
                     /note="promoter for the E. coli lac operon"
     protein_bind    complement(6333..6354)
                     /label=CAP binding site
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     rep_origin      complement(6642..7230)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     CDS             complement(7404..8261)
                     /label=AmpR
                     /note="beta-lactamase"
     promoter        complement(8262..8366)
                     /label=AmpR promoter
     rep_origin      8393..8848
                     /label=f1 ori
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"